Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring

Abstract

AbstractIntroductionDue to a steep increase in obesity, metabolic dysfunction‐associated fatty liver disease (MAFLD) has also become the most common chronic hepatic condition among children and adolescents. Various maternal and pregnancy‐related factors have also been implicated in the development of MAFLD, but human studies remain scarce.Material and methodsComprehensive data of 460 overweight or obese children aged 2–16 years were collected and combined with data on selected maternal and pregnancy‐related factors for a case–control study. MALFD was defined as alanine aminotransferase >2× upper limit of normal. Children with and without MAFLD were compared regarding to the study variables and multivariable regression analysis was utilized.ResultsMedian age of the study children was 11.8 (quartiles 9.1–14.2) years; 44% were girls and 17.8% had MAFLD. Children with MAFLD were older (12.7 vs. 11.6 years, p = 0.002), while the groups did not differ age‐standardized body mass index (BMI‐SDS) or gender. Factors associated with MAFLD in a multivariable model considering also the offspring's present BMI‐SDS, sex, and maternal prepregnancy overweight, were child's older age (odds ratio [OR] 1.16, 95% confidence interval [CI]: 1.06–1.28), maternal gestational smoking (OR 2.01, 95% CI: 1.16–3.47), gestational hypertension (OR 3.44, 95% CI: 1.08–11.0) and pre‐eclampsia (OR 2.93, 95% CI: 1.15–7.45). There was no significant association between MAFLD and maternal BMI, birth anthropometrics or perinatal complications.ConclusionsMaternal smoking, gestational hypertension and pre‐eclampsia were associated with MAFLD among overweight or obese children. Further prospective studies are needed to verify causal relationships.